SAB Biotherapeutics Inc.
SABS | NASDAQ
$3.48
+$0.09 (+2.65%)
Sep 22, 2026, 1:41 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -41.36M | -18.87M | -16.86M | 5.34M | -10.11M | -5.2M | -11.39M | -10.35M | -7.34M | -5.03M | -22.86M | -5.1M | -6.88M | -7.35M | -7.87M | -7.08M | -4.78M | 985.86K | -11.55M | -4.06M | -2.94M | 1.41M |
Depreciation & Amortization | 1.59M | 752.67K | 763.3K | 765.47K | 774.52K | 778.3K | 785.71K | 966.86K | 1.02M | 1.98M | 944.4K | 985.45K | 892.27K | 923.17K | 923.52K | 909.91K | 781K | 677.44K | 661.19K | 415.04K | 300.15K | 277.22K |
Stock-Based Compensation | 12.71M | 5.46M | 3.17M | n/a | 627.2K | 612.95K | n/a | 1.05M | 601.43K | 617.45K | 536.88K | 639.25K | 644.82K | 602.78K | 628.54K | n/a | 569.86K | 897.6K | 651.47K | 880.66K | 433.43K | 349.12K |
Other Working Capital | 1.29M | -1.57M | -7.25M | 1.85M | 783.24K | 346.78K | -2.52M | 1.83M | 115.14K | -2.82M | -321.63K | -1.27M | -44.42K | 1.65M | 1.03M | 987.48K | -1.43M | -981.88K | -1.33M | 1.06M | -613.54K | 2.94M |
Other Non-Cash Items | 1.77M | 445.79K | 3.47M | -20.78M | 618.21K | -5.06M | 3.22M | -54.53K | -2.34M | -5.72M | 10.89M | -195.47K | 50K | 10.94K | -68.81K | -206.28K | -1.73M | -7.86M | 4.49M | n/a | -1.5K | -665.6K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.53M | n/a | 357.52K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.18M | -2.06M | -7.32M | 1.62M | 942.8K | 1.06M | -1.88M | 2.1M | 263.34K | -2.77M | -427.41K | -1.49M | 37.13K | 4.21M | 6.61M | -1.8M | 707.17K | -4.23M | 871.27K | 6.56M | -4.18M | 8.08M |
Operating Cash Flow | -24.11M | -14.27M | -16.78M | -13.05M | -7.15M | -7.8M | -9.27M | -6.29M | -7.79M | -10.92M | -13.45M | -5.17M | -4.9M | -1.61M | 216.72K | -8.17M | -4.45M | -9.54M | -4.88M | 3.8M | -6.39M | 9.45M |
Capital Expenditures | -2.57M | -983.26K | -933.16K | 3 | 4 | -3 | -55.38K | -100.3K | -52.51K | -129.07K | -67.86K | -85.31K | -22.68K | -21.3K | -117.75K | -78.51K | -612.83K | -1.36M | -2.36M | -3.23M | -3.46M | -1.89M |
Cash Acquisitions | n/a | 2.22K | n/a | n/a | n/a | 500 | n/a | n/a | n/a | n/a | n/a | 44.45K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -152.28M | -139.26M | -12.04M | -129.87M | -52.02K | -70.91K | -1.31M | -4.8M | -105.01K | -31.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 84.31M | 74.6M | 11.27M | n/a | 5.25M | 4.74M | 10.69M | 3.75M | 11.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 76.39K | n/a | n/a | n/a | n/a |
Investing Cash Flow | -70.53M | -65.65M | -1.71M | -129.87M | 5.2M | 4.67M | 9.33M | -1.15M | 11.22M | -31.36M | -67.86K | -40.86K | -22.68K | -21.3K | -117.75K | -78.5K | -612.83K | -1.28M | -2.36M | -3.23M | -3.46M | -1.89M |
Debt Repayment | -76K | -37.39K | -168.77M | 168.69M | -173.84K | -171.91K | -19.21K | -649.13K | -252.33K | -247.44K | 477.76K | -142.74K | -363.79K | -361.68K | -1.07M | -32.17K | -800.18K | -804.53K | -1.15M | -51.23K | -46.23K | -45.47K |
Common Stock Repurchased | -9K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.52M | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -4.57K | -5.01K | -4.88K | n/a | -2.07K | -24.93K | -25K | n/a | n/a | n/a | n/a | n/a | 1.89K | -1 | n/a | 69.14K | 7.83K | 37.19M | n/a | n/a | n/a |
Financial Cash Flow | 92.29M | 89.92M | -41.69K | 168.69M | -173.84K | -173.99K | -44.14K | -674.13K | -252.33K | -227.03K | 67.64M | -140.31K | -363.79K | -359.79K | 6.62M | -32.17K | -731.04K | -6.32M | 36.03M | -51.23K | -46.23K | -45.47K |
Net Cash Flow | -2.24M | 10.02M | -18.92M | 25.73M | -1.95M | -3.26M | -273.21K | -8.07M | 3.21M | -42.53M | 54.14M | -5.35M | -5.29M | -1.99M | 6.71M | -8.28M | -5.79M | -17.14M | 28.79M | 518.09K | -9.9M | 7.52M |
Free Cash Flow | -26.68M | -15.25M | -17.71M | -13.05M | -7.15M | -7.8M | -9.33M | -6.39M | -7.84M | -11.05M | -13.51M | -5.25M | -4.92M | -1.63M | 98.97K | -8.25M | -5.06M | -10.9M | -7.24M | 569.32K | -9.85M | 7.56M |
Adj. Free Cash Flow | -39.39M | -20.71M | -20.88M | -13.05M | -7.78M | -8.41M | -9.33M | -7.44M | -8.44M | -11.66M | -14.05M | -5.89M | -5.57M | -2.23M | -529.57K | -8.25M | -5.63M | -11.79M | -7.89M | -311.35K | -10.28M | 7.21M |
Maintenance CapEx | -1.59M | -752.67K | -933.16K | 3 | 4 | -3 | -55.38K | -100.3K | n/a | n/a | -67.86K | -85.31K | -22.68K | -21.3K | -117.75K | -78.51K | -612.83K | -1.36M | -2.36M | -3.23M | -3.46M | -1.89M |
Growth CapEx | -982K | -230.59K | n/a | n/a | n/a | n/a | n/a | n/a | -52.51K | -129.07K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -25.7M | -15.02M | -17.71M | -13.05M | -7.15M | -7.8M | -9.33M | -6.39M | -7.79M | -10.92M | -13.51M | -5.25M | -4.92M | -1.63M | 98.97K | -8.25M | -5.06M | -10.9M | -7.24M | 569.32K | -9.85M | 7.56M |
Add to Watchlist
Select watchlists to add or remove SABS